Esperion Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Esperion Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Esperion Therapeutics Inc.
Rating: 1.52308325
Author: Trendlyne DVM scores

about

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

1.17 0.06 (5.41%)

70.30% Fall from 52W High

4.6M

XNAS Volume

XNAS 08 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.8 / 100

Technically Neutral

46.1 / 100

1Yr Price target upside is 395%

7 analysts

Esperion Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Esperion Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

70.30% Fall from 52W High

SWOT Analysis

Esperion Therapeutics Inc. Live Price Chart